Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

MorphoSys AG

www.morphosys.com

Lena-Christ-Strasse 48
Martinsried/Planegg
D-82152
Germany

+49 89 / 899 27-0

Activities

Ingredients

Related Companies

  • Lonza
  • Qualicaps
  • C-squared Pharma
  • Indena
  • Piramal Pharma Solutions
  • Boston BioProducts
  • Rousselot
  • Actylis – The Partner of Choice
  • Quotient Sciences
  • JRS Pharma
  • Icrom SRL

Related Content

MorphoSys and Immatics Biotechnologies sign immuno-oncology agreement
MorphoSys and Immatics Biotechnologies sign immuno-oncology agreement
Merck Serono and MorphoSys agree immuno-oncology collaboration
Merck Serono and MorphoSys agree immuno-oncology collaboration
MorphoSys and Heptares to develop antibody therapeutics targeting GPCRs
MorphoSys and Heptares to develop antibody therapeutics targeting GPCRs
MorphoSys expands 10-year antibody alliance with Novartis
MorphoSys expands 10-year antibody alliance with Novartis
MorphoSys makes two management appointments
MorphoSys makes two management appointments
MorphoSys unveils new antibody technology
MorphoSys unveils new antibody technology
Boehringer signs manufacturing agreement with MorphoSys
Boehringer signs manufacturing agreement with MorphoSys
MorphoSys signs Sloning technology alliance with Pfizer
MorphoSys signs Sloning technology alliance with Pfizer
MorphoSys acquires Sloning
MorphoSys acquires Sloning
MorphoSys signs anti-bacterial deal with Absynth
MorphoSys signs anti-bacterial deal with Absynth
MorphoSys to receive milestone payment from Novartis
MorphoSys to receive milestone payment from Novartis
AbD Serotec enters anti-idiotype antibodies growth area
AbD Serotec enters anti-idiotype antibodies growth area
MorphoSys granted patent on antibody technology in Japan
MorphoSys granted patent on antibody technology in Japan
MorphoSys and Galapagos expand antibody alliance
MorphoSys and Galapagos expand antibody alliance
Galapagos receives OSEO funding and Eureka innovation label
Galapagos receives OSEO funding and Eureka innovation label
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company